Mad in America: Rethinking Mental Health
Health & Fitness:Mental Health
This week we interview Dr David Healy.
Dr Healy is an internationally respected psychiatrist, psychopharmacologist, scientist, and author. A professor of Psychiatry in Wales, David studied medicine in Dublin, and at Cambridge University. He is a former Secretary of the British Association for Psychopharmacology and has authored more than 200 peer-reviewed articles and 20 books, including The Antidepressant Era and The Creation of Psychopharmacology and his latest book, Pharmageddon, published in 2012.
David is a founder and CEO of Data Based Medicine Limited, which operates through its website RxISK.org, and is dedicated to making medicines safer through online direct patient reporting of drug side effects.
In this interview, we discuss Post SSRI Sexual Dysfunction (PSSD) and Dr Healy’s novel and innovative approach to finding a cure.
A recent email to Dr Healy starkly highlights the problem:
I took X for 16 years without any side effects. Stopped 7 months ago and all hell broke loose. Some of the side effects I got in the first week after quitting are: no libido, cold testicles/penis, pain around penis and anus, tinnitus, erectile dysfunction, tingling, numbness...
Life is not very good these days.
I am married with beautiful children. They have lost their father. If I can do anything to help, don't hesitate to get in touch. I would like to give you my biggest thanks for what you are doing and wish you all the best with the fundraising.
In the episode we discuss:
How Dr Healy came to set up Data Based medicine and RxISK.org. Why RxISK are focussing on Post SSRI Sexual Dysfunction (PSSD). That genital numbness can occur very quickly upon taking an ssri antidepressant and can also be triggered by drugs such as Roaccutane (isotretinoin) and Propecia (finasteride). What led to setting up the RxISK Prize. How people can get involved with the campaign. That it’s often people not involved with healthcare who get motivated to take action. How empowering it is to enable people harmed by pills to be part of the solution.To get in touch with us email: podcasts@madinamerica.com
© Mad in America 2017
Demedicalizing Depression: An Interview with Milutin Kostić
Leaving Biological Psychiatry Behind - An Interview With Rodrigo Nardi
Context and Care vs Isolate and Control - An Interview with Arthur Kleinman
Undisclosed Financial Conflicts of Interest in the DSM-5: An interview with Lisa Cosgrove and Brian Piper
Deprescribing Psychiatric Drugs to Reduce Harms and Empower Patients - Swapnil Gupta
Is Madness an Evolved Signal? – Justin Garson on Strategy Versus Dysfunction
'It Was a Joint Effort'- Deborah Kasdan on Bringing Her Late Sister's Story to Life
What if Much of What you Thought you Knew About Mental Health was up for Debate?
The Psychological Humanities Manifesto: An Interview with Mark Freeman
Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs
Robert Whitaker Answers Reader Questions on Mad in America, the Biopsychosocial Model, and Psychiatric History
The Making of a 'Madness' That Hides Our Monsters - An Interview with Audrey Clare Farley
A Playground for Predators-Diane Dimond on The Abuses of Guardianship
May Cause Side Effects–Radical Acceptance and Psychiatric Drug Withdrawal: An Interview with Brooke Siem
Branding Diseases: Ray Moynihan on How Drug Companies Market Psychiatric Conditions
How Mad Studies and the Psychological Humanities are Changing Mental Health: An Interview with Narrative Psychiatrist Bradley Lewis
Embracing the Shadow—Charlie Morley on Lucid Dreaming as Therapy
Family Panel Discussion – Supporting a Child, Teen, or Young Person in Crisis
Sacred Conversations: A Talk with Susan Swim and a Father Whose Daughter Found Healing
The Radical Politics of Madness-Micha Frazer-Carroll
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Mental Health Insights
MQ Open Mind
Speaking of Suicide
The Suicide Prevention Movement
Depression Talks Podcast